|
Sofinnova is the name shared by two venture capital firms, Sofinnova Ventures and Sofinnova Partners. Both firms trace their roots back to Sofinnova SA, an investment institution founded in Paris in 1972. The two firms have raised ~$4B since inception, and shared a similar investment strategy of investing in the life science and technology sectors. The two sister firms distinguish themselves on the basis of their target geographies, and have been fully independent since 1997. * Sofinnova Ventures has offices in Menlo Park, CA and San Diego, CA and focuses largely on US biotech investments, with ~20% allocation for Europe. * Sofinnova Partners is based in Paris and focuses primarily on European biotech and cleantech investments, with a similar reciprocal allocation for the US. Sofinnova Ventures and Sofinnova Partners have had historically some of the same Limited Partners, and have co-invested together in selected companies from their respective funds. Both firms work together in a collegial way to exchange information and due diligence in each other's respective geographies. The firms do not have an obligation to show each other deals or to co-invest, but historically have co-invested together in ~10% of their collective investments. ==Sofinnova Ventures (USA)== Sofinnova Ventures is an independent venture capital firm based in Menlo Park with $1.9B capital under management.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Sofinnova」の詳細全文を読む スポンサード リンク
|